Vringo receives six-month delisting reprieve

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Vringo receives six-month delisting reprieve

The patent assertion entity announced today that it has received a six-month grace period to raise its share price to the $1 minimum

The US-based PAE has been involved in several high profile lawsuits, including a string of cases involving standards essential patents against Chinese telecommunications company ZTE around the world (venues include the UK, Germany, India, Romania and Brazil).

In 2012, Vringo won a $30 million judgment against Google after a district court found that the search engine’s AdWords and AdSense programs infringed patents Vringo acquired from Lycos. Last year, the Federal Circuit overturned the verdict, causing Vringo’s stock price to tumble from $3.15 to $0.88 per share. The price then hovered around $1, the minimum required to be listed on the NASDAQ, but since December 1 has been trading for less than that.

As of writing, VRNG is trading at slightly above 60 cents a share.

Vringo’s announcement comes at a time when there is some concern about the viability of the PAE business model. A study from RPX showed that 2014 saw a significant drop in NPE-initiated litigation activity, and there was a decrease in patent litigation overall. This year however has seen a rebound in the number in the number of patent cases filed. And recently, Ray Niro, considered by some to be one of the first patent rolls, said that the Supreme Court decision in Octane Fitness has increased the risk to plaintiffs may lead to him leaving the NPE business.

more from across site and SHARED ros bottom lb

More from across our site

Licensing chief Patrik Hammarén also reveals that the company will rename its IPR business to better reflect its role in defining standards
The acquisition of Pecher & Partners follows the firm’s earlier expansion into litigation to create a ‘one-stop shop’
News of Via Licensing Alliance launching its first semiconductor patent pool and INTA electing a new president were also among the top talking points
Submit your nominations to this year's WIBL Americas Awards by January 23
The 2026 Life Sciences EMEA Awards is now open for entries. We are looking forward to reviewing and celebrating the industry's most impressive achievements and landmarks from the past year.
The tie-up between Perkins Coie and Ashurst may generate some striking numbers, but independent IP firms need not worry yet, according to practitioners
Perkins Coie’s US patent prosecution strength could provide Ashurst with an opportunity to enter an untapped market in Australia, but it may not be easy
Mitesh Patel at Reed Smith outlines why the US Copyright Office and courts have so far dismissed AI authorship and how inventors can protect AI-generated works
Xia Zheng, founder of AFD China, discusses balancing legal work with BD, new approaches to complex challenges, and the dangers of ‘over-optimism’
A dispute involving semiconductor technology and a partner's move from Hoffman Eitle to Hoyng Rokh Monegier were also among the top talking points
Gift this article